Skip NavigationSkip to Content

A high-throughput cell-based assay to identify specific inhibitors of transcription factor AP-1

  1. Author:
    Ruocco, K. M.
    Goncharova, E. I.
    Young, M. R.
    Colburn, N. H.
    McMahon, J. B.
    Henrich, C. J.
  2. Author Address

    NCI, SAIC Frederick Inc, Basic Res Program, Frederick, MD 21702 USA. NCI, Lab Canc Prevent, Gene Regulat Sect, Frederick, MD 21702 USA. NCI, Mol Targets Dev Program, Frederick, MD 21702 USA. NCI, Data Management Serv Inc, Frederick, MD 21702 USA.;Henrich, CJ, NCI, SAIC Frederick Inc, Basic Res Program, Bldg 560,Room 32-63A, Frederick, MD 21702 USA.;henrichc@ncifcrf.gov
    1. Year: 2007
    2. Date: Feb
  1. Journal: Journal of Biomolecular Screening
    1. 12
    2. 1
    3. Pages: 133-139
  2. Type of Article: Article
  3. ISSN: 1087-0571
  1. Abstract:

    The oncogenic transcription factor AP-1 (activator protein-1) is required for tumor promotion and progression. Identification of novel and specific AP-1 inhibitors would be beneficial for cancer prevention and therapy. The authors have developed a high-throughput assay to screen synthetic and natural product libraries for noncytotoxic inhibitors of mitogen-activated AP-1 activity. The cell-based high-throughput screen is conducted in a 384-well format using a fluorescent resonance energy transfer (FRET) substrate to quantify the activity of a beta-lactamase reporter under the control of an AP-1-dependent promoter. The ratiometric FRET readout makes this assay extremely robust and reproducible, particularly for use with natural product extracts. To eliminate false positives due to cell killing, a cytotoxicity assay was incorporated. The AP-1 beta-lactamase reporter was validated with inhibitors of kinases located upstream of AP-1 and with known natural product inhibitors of AP-1 (nordihydroguaiaretic acid and curcumin). The assay was able to identify other known AP-1 inhibitors and protein kinase C modulators, as well as a number of chemically diverse compounds with unknown mechanisms of action from natural products libraries. Application to natural product extracts identified hits from a range of taxonomic groups. Screening of synthetic compounds and natural products should identify novel AP-1 inhibitors that may be useful in the prevention and treatment of cancers.

    See More

External Sources

  1. DOI: 10.1177/1087057106296686
  2. WOS: 000244249000014

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel